Screener
Charles River Laboratories CRL RMS — Goodwill impairment
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:GoodwillImpairmentLoss.
The source filing: Charles River Laboratories’s 10-K, filed February 18, 2026.
- Filed
- Feb 18, 2026, 9:21 AM EST
- Fiscal year
- FY2025
- Accession
- 0001100682-26-000022
| Line item | RMS | DSA(1) | Manufacturing (2) | Total |
|---|---|---|---|---|
| December 30, 2023 | $497,474 | $1,662,434 | $935,137 | $3,095,045 |
| Acquisitions | — | 17,675 | — | 17,675 |
| Impairment | — | — | (215,000) | (215,000) |
| Foreign exchange | (734) | (44,458) | (5,920) | (51,112) |
| December 28, 2024 | 496,740 | 1,635,651 | 714,217 | 2,846,608 |
| Divestitures | — | (4,000) | — | (4,000) |
| Impairment | — | — | (165,000) | (165,000) |
| Foreign exchange | 14,104 | 46,867 | 25,674 | 86,645 |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Charles River Laboratories's RMS — goodwill impairment?
- Charles River Laboratories (CRL) reported RMS — goodwill impairment of $0 in Q4 2025.
- What does RMS — goodwill impairment mean?
- This metric represents the impairment charge taken against goodwill associated with the Research Models and Services segment. It occurs when the fair value of the reporting unit falls below its carrying amount, necessitating a write-down of the goodwill asset.
Ask your AI about Charles River Laboratories's rms — goodwill impairment.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude